|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions decreases activity increases expression |
ISO |
Mitotane inhibits the reaction [ABCB1 protein results in increased export of Daunorubicin] Mitotane results in decreased activity of ABCB1 protein Mitotane results in increased expression of ABCB1 mRNA |
CTD |
PMID:1675220 PMID:9815696 PMID:12015757 PMID:31312845 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Aldh1l2 |
aldehyde dehydrogenase 1 family, member L2 |
increases expression |
ISO |
Mitotane results in increased expression of ALDH1L2 mRNA |
CTD |
PMID:22966885 |
|
NCBI chr 7:20,254,246...20,305,793
Ensembl chr 7:20,254,233...20,305,776
|
|
G |
Ar |
androgen receptor |
multiple interactions affects binding |
ISO EXP |
Mitotane binds to and results in decreased activity of AR protein; Mitotane inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Mitotane inhibits the reaction [Dihydrotestosterone binds to AR protein] Mitotane binds to AR protein |
CTD |
PMID:9705896 PMID:14565775 PMID:14579009 PMID:33049310 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Aven |
apoptosis and caspase activation inhibitor |
increases expression |
EXP |
Mitotane analog results in increased expression of AVEN mRNA; Mitotane results in increased expression of AVEN mRNA |
CTD |
PMID:23485034 |
|
NCBI chr 3:99,299,009...99,431,635
Ensembl chr 3:99,298,930...99,431,634
|
|
G |
Bag1 |
BAG cochaperone 1 |
increases expression |
EXP |
Mitotane results in increased expression of BAG1 mRNA |
CTD |
PMID:23485034 |
|
NCBI chr 5:56,068,494...56,081,075
Ensembl chr 5:56,068,494...56,081,075
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
increases expression |
EXP |
Mitotane results in increased expression of BAK1 mRNA |
CTD |
PMID:23485034 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
EXP ISO |
Mitotane analog results in increased expression of BAX mRNA; Mitotane results in increased expression of BAX mRNA [Doxorubicin co-treated with Vincristine co-treated with Etoposide co-treated with Mitotane] results in decreased expression of BAX protein |
CTD |
PMID:9815696 PMID:23485034 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases expression multiple interactions |
EXP ISO |
Mitotane results in increased expression of BCL2 mRNA [Doxorubicin co-treated with Vincristine co-treated with Etoposide co-treated with Mitotane] results in decreased expression of BCL2 protein |
CTD |
PMID:9815696 PMID:23485034 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2a1 |
BCL2-related protein A1 |
increases expression |
EXP |
Mitotane results in increased expression of BCL2A1 mRNA |
CTD |
PMID:23485034 |
|
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
increases expression |
EXP |
Mitotane results in increased expression of BCL2L11 mRNA |
CTD |
PMID:23485034 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Bcl2l2 |
Bcl2-like 2 |
increases expression |
EXP |
Mitotane results in increased expression of BCL2L2 mRNA |
CTD |
PMID:23485034 |
|
NCBI chr15:28,346,449...28,361,627
Ensembl chr15:28,356,807...28,361,624
|
|
G |
Bdkrb1 |
bradykinin receptor B1 |
increases activity |
EXP |
Mitotane results in increased activity of BDKRB1 protein |
CTD |
PMID:11159707 |
|
NCBI chr 6:124,510,827...124,514,475
Ensembl chr 6:124,510,870...124,513,747
|
|
G |
Bid |
BH3 interacting domain death agonist |
increases expression |
EXP |
Mitotane analog results in increased expression of BID mRNA; Mitotane results in increased expression of BID mRNA |
CTD |
PMID:23485034 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
increases expression |
EXP |
Mitotane results in increased expression of BIRC3 mRNA |
CTD |
PMID:23485034 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
increases expression |
EXP |
Mitotane analog results in increased expression of BNIP3 mRNA; Mitotane results in increased expression of BNIP3 mRNA |
CTD |
PMID:23485034 |
|
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Casp1 |
caspase 1 |
increases expression |
EXP |
Mitotane results in increased expression of CASP1 mRNA |
CTD |
PMID:23485034 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp12 |
caspase 12 |
increases expression |
EXP |
Mitotane analog results in increased expression of CASP12 mRNA; Mitotane results in increased expression of CASP12 mRNA |
CTD |
PMID:23485034 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp2 |
caspase 2 |
increases expression |
EXP |
Mitotane results in increased expression of CASP2 mRNA |
CTD |
PMID:23485034 |
|
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
|
|
G |
Casp3 |
caspase 3 |
increases expression increases activity |
EXP ISO |
Mitotane results in increased expression of CASP3 mRNA Mitotane results in increased activity of CASP3 protein |
CTD |
PMID:23254310 PMID:23485034 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp4 |
caspase 4 |
increases expression |
EXP |
Mitotane analog results in increased expression of CASP4 mRNA; Mitotane results in increased expression of CASP4 mRNA |
CTD |
PMID:23485034 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Casp7 |
caspase 7 |
increases activity increases expression |
ISO EXP |
Mitotane results in increased activity of CASP7 protein Mitotane results in increased expression of CASP7 mRNA |
CTD |
PMID:23254310 PMID:23485034 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8ap2 |
caspase 8 associated protein 2 |
increases expression |
EXP |
Mitotane analog results in increased expression of CASP8AP2 mRNA; Mitotane results in increased expression of CASP8AP2 mRNA |
CTD |
PMID:23485034 |
|
NCBI chr 5:47,014,501...47,052,276
Ensembl chr 5:47,014,667...47,052,275
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions |
ISO |
Mitotane results in increased expression of and results in increased localization of CCNB1 protein |
CTD |
PMID:18509009 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
increases expression |
EXP |
Mitotane analog results in increased expression of CFLAR mRNA |
CTD |
PMID:23485034 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Cideb |
cell death-inducing DFFA-like effector b |
decreases expression increases expression |
EXP |
Mitotane analog results in decreased expression of CIDEB mRNA Mitotane analog results in increased expression of CIDEB mRNA |
CTD |
PMID:23485034 |
|
NCBI chr15:29,252,208...29,256,482
Ensembl chr15:29,252,213...29,256,605
|
|
G |
Cox4i1 |
cytochrome c oxidase subunit 4i1 |
decreases expression |
ISO |
Mitotane results in decreased expression of COX4I1 mRNA |
CTD |
PMID:23696597 |
|
NCBI chr19:48,721,680...48,727,920
Ensembl chr19:48,721,199...48,727,921
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
increases activity |
ISO |
Mitotane results in increased activity of CREB1 protein |
CTD |
PMID:18791200 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Crebbp |
CREB binding protein |
increases activity |
ISO |
Mitotane results in increased activity of CREBBP protein |
CTD |
PMID:22609851 |
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
decreases expression multiple interactions decreases activity |
ISO |
Mitotane results in decreased expression of CYP11A1 mRNA; Mitotane results in decreased expression of CYP11A1 protein Mitotane inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 mRNA] Mitotane results in decreased activity of CYP11A1 protein |
CTD |
PMID:6094274 PMID:22546480 PMID:23254310 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
increases expression multiple interactions decreases expression |
ISO |
Mitotane results in increased expression of CYP11B1 mRNA Mitotane affects the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11B1 mRNA] Mitotane results in decreased expression of CYP11B1 protein |
CTD |
PMID:19900470 PMID:22546480 PMID:23696597 |
|
NCBI chr 7:106,838,590...106,845,004
Ensembl chr 7:106,838,590...106,845,004
|
|
G |
Cyp11b3 |
cytochrome P450, family 11, subfamily b, polypeptide 3 |
decreases expression |
ISO |
Mitotane results in decreased expression of CYP11B2 protein |
CTD |
PMID:23696597 |
|
NCBI chr 7:106,808,559...106,814,048
Ensembl chr 7:106,808,559...106,814,048
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
decreases expression multiple interactions |
ISO |
Mitotane results in decreased expression of CYP17A1 mRNA Mitotane inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 mRNA] |
CTD |
PMID:22546480 PMID:23254310 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
increases expression |
EXP |
Mitotane results in increased expression of CYP2B2 mRNA |
CTD |
PMID:10036216 |
|
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
affects abundance increases expression multiple interactions |
ISO |
CYP2B6 gene polymorphism affects the abundance of Mitotane; CYP2B6 protein affects the abundance of Mitotane Mitotane results in increased expression of CYP2B6 mRNA [Mitotane co-treated with NR1I3 protein alternative form] results in increased expression of CYP2B6 mRNA; [Mitotane co-treated with NR1I3 protein mutant form] results in increased expression of CYP2B6 mRNA |
CTD |
PMID:23524664 PMID:31312845 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions increases expression increases activity |
ISO |
[Mitotane results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; Mitotane promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]; NR1I2 protein promotes the reaction [Mitotane results in increased expression of CYP3A4 mRNA] Mitotane results in increased activity of CYP3A4 protein |
CTD |
PMID:23179081 PMID:31312845 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Dapk1 |
death associated protein kinase 1 |
increases expression |
EXP |
Mitotane results in increased expression of DAPK1 mRNA |
CTD |
PMID:23485034 |
|
NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991
|
|
G |
Dffa |
DNA fragmentation factor subunit alpha |
increases expression |
EXP |
Mitotane results in increased expression of DFFA mRNA |
CTD |
PMID:23485034 |
|
NCBI chr 5:159,540,715...159,553,639
Ensembl chr 5:159,540,715...159,553,633
|
|
G |
Dffb |
DNA fragmentation factor subunit beta |
increases expression |
EXP |
Mitotane results in increased expression of DFFB mRNA |
CTD |
PMID:23485034 |
|
NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628
|
|
G |
Elk1 |
ETS transcription factor ELK1 |
increases activity |
ISO |
Mitotane results in increased activity of ELK1 protein |
CTD |
PMID:18791200 |
|
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
|
|
G |
Esr1 |
estrogen receptor 1 |
increases activity affects binding multiple interactions |
ISO EXP |
Mitotane results in increased activity of ESR1 protein Mitotane binds to ESR1 protein ESR1 protein promotes the reaction [Mitotane results in increased expression of SERPINA6 protein]; ESR1 protein promotes the reaction [Mitotane results in increased expression of SHBG protein]; Mitotane binds to and results in increased activity of ESR1 protein; Mitotane inhibits the reaction [Estradiol binds to ESR1 protein] Mitotane inhibits the reaction [Estradiol binds to ESR1 protein]; Mitotane inhibits the reaction [Estradiol results in increased activity of ESR1 protein] |
CTD |
PMID:8930550 PMID:10580743 PMID:14579009 PMID:16551731 PMID:26139245 PMID:28531659 PMID:33049310 More...
|
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
increases activity multiple interactions |
ISO |
Mitotane results in increased activity of ESR2 protein Mitotane binds to and results in increased activity of ESR2 protein |
CTD |
PMID:26139245 PMID:33049310 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Faslg |
Fas ligand |
increases expression |
EXP |
Mitotane results in increased expression of FASLG mRNA |
CTD |
PMID:23485034 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fasn |
fatty acid synthase |
decreases expression |
ISO |
Mitotane results in decreased expression of FASN mRNA |
CTD |
PMID:31312845 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
decreases expression |
ISO |
Mitotane results in decreased expression of G6PC1 mRNA |
CTD |
PMID:31312845 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression |
EXP |
Mitotane analog results in increased expression of GADD45A mRNA; Mitotane results in increased expression of GADD45A mRNA |
CTD |
PMID:23485034 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
Mitotane results in increased expression of GDF15 mRNA |
CTD |
PMID:22966885 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
increases expression |
EXP |
Mitotane analog results in increased expression of GPX2 mRNA; Mitotane results in increased expression of GPX2 mRNA |
CTD |
PMID:23485034 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
increases expression |
EXP |
Mitotane analog results in increased expression of GSTA2 mRNA |
CTD |
PMID:23485034 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
multiple interactions |
ISO |
Mitotane inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate] |
CTD |
PMID:23769903 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
decreases expression |
ISO |
Mitotane results in decreased expression of HSD3B1 mRNA |
CTD |
PMID:22966885 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Hsd3b2 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
decreases expression multiple interactions |
ISO |
Mitotane results in decreased expression of HSD3B2 mRNA Mitotane inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD3B2 mRNA] |
CTD |
PMID:19900470 PMID:22546480 PMID:22966885 |
|
NCBI chr 2:186,095,897...186,105,354
Ensembl chr 2:186,095,897...186,101,852
|
|
G |
Hsp90aa1 |
heat shock protein 90 alpha family class A member 1 |
increases expression |
EXP |
Mitotane analog results in increased expression of HSP90AA1 mRNA; Mitotane results in increased expression of HSP90AA1 mRNA |
CTD |
PMID:23485034 |
|
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
|
|
G |
Hspa4 |
heat shock protein family A (Hsp70) member 4 |
increases expression |
EXP |
Mitotane analog results in increased expression of HSPA4 mRNA |
CTD |
PMID:23485034 |
|
NCBI chr10:37,408,025...37,449,080
Ensembl chr10:37,408,025...37,449,001
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
increases expression |
EXP |
Mitotane results in increased expression of HSPD1 mRNA |
CTD |
PMID:23485034 |
|
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
|
|
G |
Ifnb1 |
interferon beta 1 |
increases response to substance multiple interactions |
ISO |
IFNB1 protein results in increased susceptibility to Mitotane Mitotane promotes the reaction [IFNB1 protein results in decreased secretion of Hydrocortisone] |
CTD |
PMID:23507702 |
|
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
|
|
G |
Mapk8ip1 |
mitogen-activated protein kinase 8 interacting protein 1 |
increases expression |
EXP |
Mitotane analog results in increased expression of MAPK8IP1 mRNA; Mitotane results in increased expression of MAPK8IP1 mRNA |
CTD |
PMID:23485034 |
|
NCBI chr 3:78,355,051...78,372,946
Ensembl chr 3:78,355,048...78,372,884
|
|
G |
Mt-co2 |
mitochondrially encoded cytochrome c oxidase II |
decreases expression |
ISO |
Mitotane results in decreased expression of COX2 mRNA |
CTD |
PMID:23696597 |
|
NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689
Ensembl chr MT:7,006...7,689
|
|
G |
Ncoa1 |
nuclear receptor coactivator 1 |
multiple interactions |
ISO |
Mitotane promotes the reaction [NCOA1 protein binds to NR1I2 protein]; Mitotane promotes the reaction [NCOA1 protein binds to NR1I3 protein] |
CTD |
PMID:23179081 PMID:31312845 |
|
NCBI chr 6:27,232,609...27,507,992
Ensembl chr 6:27,232,611...27,475,664
|
|
G |
Ncoa3 |
nuclear receptor coactivator 3 |
multiple interactions |
ISO |
Mitotane promotes the reaction [NCOA3 protein binds to NR1I3 protein] |
CTD |
PMID:31312845 |
|
NCBI chr 3:154,738,566...154,821,395
Ensembl chr 3:154,738,581...154,818,594
|
|
G |
Nol3 |
nucleolar protein 3 |
increases expression |
EXP |
Mitotane results in increased expression of NOL3 mRNA |
CTD |
PMID:23485034 |
|
NCBI chr19:33,154,061...33,158,250
Ensembl chr19:33,154,062...33,158,250
|
|
G |
Notch1 |
notch receptor 1 |
increases activity |
ISO |
Mitotane results in increased activity of NOTCH1 protein |
CTD |
PMID:18791200 |
|
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions increases activity |
ISO |
[Mitotane results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; Mitotane binds to and results in increased activity of NR1I2 protein; Mitotane promotes the reaction [NCOA1 protein binds to NR1I2 protein]; Mitotane promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]; NR1I2 protein promotes the reaction [Mitotane results in increased expression of CYP3A4 mRNA] |
CTD |
PMID:23179081 PMID:31312845 PMID:33049310 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
increases activity affects localization multiple interactions affects binding |
ISO |
Mitotane results in increased activity of NR1I3 protein Mitotane affects the localization of NR1I3 protein mutant form [Mitotane co-treated with NR1I3 protein alternative form] results in increased expression of CYP2B6 mRNA; [Mitotane co-treated with NR1I3 protein mutant form] results in increased expression of CYP2B6 mRNA; Mitotane binds to and results in increased activity of NR1I3 protein alternative form; Mitotane inhibits the reaction [ethyl (5-(diethylglycyl)-10,11-dihydro-5H-dibenzo(b,f)azepin-3-yl)carbamate results in decreased activity of NR1I3 protein]; Mitotane promotes the reaction [NCOA1 protein binds to NR1I3 protein]; Mitotane promotes the reaction [NCOA3 protein binds to NR1I3 protein] Mitotane binds to NR1I3 protein |
CTD |
PMID:28927721 PMID:31312845 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 |
decreases expression |
ISO |
Mitotane results in decreased expression of PCK1 mRNA |
CTD |
PMID:31312845 |
|
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
|
|
G |
Pgr |
progesterone receptor |
multiple interactions affects binding |
ISO |
Mitotane inhibits the reaction [Progesterone binds to PGR protein] Mitotane binds to PGR protein |
CTD |
PMID:14579009 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
ISO |
Mitotane binds to and results in increased activity of PPARG protein |
CTD |
PMID:33049310 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Prkar1a |
protein kinase cAMP-dependent type I regulatory subunit alpha |
decreases expression |
ISO |
Mitotane results in decreased expression of PRKAR1A mRNA |
CTD |
PMID:23254310 |
|
NCBI chr10:94,621,042...94,639,534
Ensembl chr10:94,620,039...94,639,041
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression |
ISO |
Mitotane results in increased expression of PTGS2 protein |
CTD |
PMID:23132776 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ripk2 |
receptor-interacting serine-threonine kinase 2 |
increases expression |
EXP |
Mitotane results in increased expression of RIPK2 mRNA |
CTD |
PMID:23485034 |
|
NCBI chr 5:29,630,806...29,662,804
Ensembl chr 5:29,631,570...29,662,657
|
|
G |
Rrm1 |
ribonucleotide reductase catalytic subunit M1 |
increases expression decreases response to substance |
ISO |
Mitotane results in increased expression of RRM1 mRNA RRM1 protein results in decreased susceptibility to Mitotane |
CTD |
PMID:22547773 |
|
NCBI chr 1:156,823,960...156,848,262
Ensembl chr 1:156,823,960...156,848,261
|
|
G |
Scd |
stearoyl-CoA desaturase |
decreases expression |
ISO |
Mitotane results in decreased expression of SCD mRNA |
CTD |
PMID:31312845 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Serpina6 |
serpin family A member 6 |
increases expression multiple interactions |
ISO |
Mitotane results in increased expression of SERPINA6 protein ESR1 protein promotes the reaction [Mitotane results in increased expression of SERPINA6 protein] |
CTD |
PMID:16551731 |
|
NCBI chr 6:122,780,040...122,790,274
Ensembl chr 6:122,780,043...122,790,349
|
|
G |
Serpine2 |
serpin family E member 2 |
increases expression |
ISO |
Mitotane results in increased expression of SERPINE2 mRNA |
CTD |
PMID:22966885 |
|
NCBI chr 9:81,124,746...81,188,866
Ensembl chr 9:81,124,804...81,188,826
|
|
G |
Shbg |
sex hormone binding globulin |
increases expression multiple interactions affects binding |
ISO |
Mitotane results in increased expression of SHBG protein ESR1 protein promotes the reaction [Mitotane results in increased expression of SHBG protein] Mitotane binds to SHBG protein |
CTD |
PMID:16551731 PMID:25349334 |
|
NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057
|
|
G |
Sod1 |
superoxide dismutase 1 |
increases expression |
EXP |
Mitotane analog results in increased expression of SOD1 mRNA; Mitotane results in increased expression of SOD1 mRNA |
CTD |
PMID:23485034 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
increases expression |
EXP |
Mitotane analog results in increased expression of SOD2 mRNA |
CTD |
PMID:23485034 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Star |
steroidogenic acute regulatory protein |
multiple interactions decreases expression |
ISO |
Mitotane inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA] Mitotane results in decreased expression of STAR mRNA; Mitotane results in decreased expression of STAR protein |
CTD |
PMID:22546480 PMID:23696597 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
decreases expression |
ISO |
Mitotane results in decreased expression of TGFB1 mRNA |
CTD |
PMID:23254310 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Thrsp |
thyroid hormone responsive |
decreases expression |
ISO |
Mitotane results in decreased expression of THRSP mRNA |
CTD |
PMID:31312845 |
|
NCBI chr 1:151,723,415...151,727,740
Ensembl chr 1:151,723,086...151,728,075
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
increases expression |
EXP |
Mitotane results in increased expression of TNFRSF1A mRNA |
CTD |
PMID:23485034 |
|
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
|
|
G |
Tnfrsf1b |
TNF receptor superfamily member 1B |
increases expression |
EXP |
Mitotane analog results in increased expression of TNFRSF1B mRNA; Mitotane results in increased expression of TNFRSF1B mRNA |
CTD |
PMID:23485034 |
|
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
|
|
G |
Tp53 |
tumor protein p53 |
affects expression increases expression multiple interactions |
EXP ISO |
Mitotane analog affects the expression of TP53 protein Mitotane analog results in increased expression of TP53 mRNA; Mitotane results in increased expression of TP53 mRNA; Mitotane results in increased expression of TP53 protein [Doxorubicin co-treated with Vincristine co-treated with Etoposide co-treated with Mitotane] results in decreased expression of TP53 protein |
CTD |
PMID:9815696 PMID:23485034 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp53bp2 |
tumor protein p53 binding protein, 2 |
increases expression |
EXP |
Mitotane results in increased expression of TP53BP2 mRNA |
CTD |
PMID:23485034 |
|
NCBI chr13:94,088,769...94,145,436
Ensembl chr13:94,088,709...94,145,432
|
|
G |
Traf2 |
Tnf receptor-associated factor 2 |
increases expression |
EXP |
Mitotane results in increased expression of TRAF2 mRNA |
CTD |
PMID:23485034 |
|
NCBI chr 3:8,341,950...8,366,609
Ensembl chr 3:8,341,951...8,366,538
|
|
G |
Traf4 |
Tnf receptor associated factor 4 |
increases expression |
EXP |
Mitotane results in increased expression of TRAF4 mRNA |
CTD |
PMID:23485034 |
|
NCBI chr10:63,054,169...63,060,284
Ensembl chr10:63,054,181...63,060,284
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
increases expression |
ISO |
Mitotane results in increased expression of TRIB3 mRNA |
CTD |
PMID:22966885 |
|
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
|
|
G |
Ugt2b1 |
UDP glucuronosyltransferase 2 family, polypeptide B1 |
increases expression |
EXP |
Mitotane results in increased expression of UGT2B1 mRNA |
CTD |
PMID:10036216 |
|
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
increases expression |
EXP |
Mitotane analog results in increased expression of XIAP mRNA |
CTD |
PMID:23485034 |
|
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
|
|